SERVICES
Breast 360 Breast Cancer Screening
Early detection doesn’t have to be invasive to be powerful.
DNA Breast 360 is a simple, non-invasive breast cancer screening test.
It checks for early warning signs of breast cancer using a small sample of your tears.
How The DNA Breast 360 – Breast Cancer Screening Works
You collect your sample with a soft tear strip. It is quick and painless.
The test looks for two special proteins in your tears.
These proteins can rise when there is inflammation or possible cancer in the breast.
This test may be helpful for:
Women under 50
Women with dense breast tissue
Women who do not have easy access to regular screenings
The test has 92% sensitivity, which means it can often detect early signs when cancer is most treatable.
The test measures two proteins called S100A8 and S100A9, along with your age, to calculate your personal result.
A “clinically significant” result does not mean you have cancer.
It means something unusual was found. If this happens, more testing is needed to rule out cancer.
DNA Breast 360 is designed to help find possible problems early—so you can take the next steps with your doctor if needed.
Simple At-Home Testing
The DNA Breast 360 kit allows you to collect your sample in the privacy of your own home.
Your kit includes:
Instruction booklet
Sample tube
Two sample strips
Sample solution
Sample label
Return pouch
1h consulting Session once the results are back
Before collecting your sample, register your kit online using the activation code on your lab form. This links your sample to you when it arrives at the lab.
Follow the instructions to collect a tear sample, then send it back using the return pouch. Once testing is complete, you can view your results online.
The Power of Early Insight in Protecting Your Health
Be Proactive:
Early Screening Can Save Lives
The American Cancer Society reports that when breast cancer is detected early (before it spreads), the survival rate is about 99%.
The DNA Breast 360 test looks for two proteins in your tears—S100A8 (Calgranulin A) and S100A9 (Calgranulin B). These proteins are linked to inflammation in the body and can be elevated in people with breast cancer. Detecting these markers may help identify potential concerns earlier, giving you the chance to take action sooner.
Use It Alongside
Regular Screening
The DNA Breast 360 test is designed to complement—not replace—traditional screening methods such as mammograms or imaging.
Because breast cancer treatments are most effective when started early, regular screening is important. This simple, non-invasive test can serve as an additional early warning tool, especially for:
Younger women
People with limited access to regular imaging
Anyone wanting additional insight into their breast health
Understanding
Your Results
Your results will be reported as either:
Negative – No clinically significant biomarkers detected
Clinically Significant – Biomarkers associated with breast cancer were detected
Important notes:
A clinically significant result is not a cancer diagnosis.
False positives and false negatives are possible.
You will have the opportunity to discuss your results with one of the program’s clinicians or your own healthcare provider to determine the appropriate next steps.
Gain
Peace of Mind
If you are worried about your breast cancer risk due to family history or genetics, the DNA Breast 360 test may provide helpful information.
Research shows the test has about 92% sensitivity for detecting clinically significant activity associated with breast cancer. This means it may help identify potential problems early, allowing for earlier monitoring, treatment, or preventive care.
Even if the results indicate a concern, the information can help you and your healthcare provider take the next steps toward protecting your health.
DNA Breast 360 FAQ's
What Is DNA Breast 360?
DNA Breast 360 is a non-invasive screening test that looks for early signs of breast cancer by analyzing certain proteins in your tears.
It is meant to be used alongside traditional screening methods, such as mammograms, to give you additional insight into your breast health.
How Does the Test Work?
The test uses a small paper strip called a Schirmer strip that is gently placed inside your lower eyelid to collect a tear sample.
The strip absorbs your tears, which are then sent to a laboratory. Scientists analyze the sample for specific protein biomarkers that may be linked to breast cancer.
Why Are Tears Used Instead of Blood?
Tears can provide a cleaner sample for detecting certain biomarkers.
Blood contains large components such as red blood cells, white blood cells, and many proteins that can make it harder to detect small disease markers. Tears do not contain these larger components, which may allow for more precise detection of certain proteins.
Who Should Use DNA Breast 360?
The test is designed for women ages 30 and older who want to monitor their breast health.
It may be especially helpful for:
• Women under 50 who are not routinely screened with mammograms
• People who have limited access to imaging services
• Those living in rural or underserved areas
• Anyone who wants additional information about their breast health
How Often Should I Take the Test?
Most people are advised to take the test once a year, or as recommended by their healthcare provider.
Regular testing helps track changes over time and may help identify potential concerns earlier.
Does It Replace Mammograms?
No. DNA Breast 360 is not a replacement for mammograms.
It is designed to complement traditional screening methods, providing additional information about breast health—especially for younger women or those who may face barriers to regular imaging.
How Accurate Is the Test?
Clinical studies show the test has about 92% sensitivity for detecting clinically significant activity related to breast cancer.
This means it can be effective at identifying potential issues that may need further medical evaluation.
What Do the Results Mean?
Results are reported as either:
Negative (Not Clinically Significant)
• No significant biomarkers were detected.
• Continue routine breast screenings as recommended.
Positive (Clinically Significant)
• Elevated biomarkers associated with breast cancer were detected.
• Follow-up testing may be recommended, such as mammography, thermography, or ultrasound.
A positive result does not mean you have cancer. It indicates that further evaluation may be needed.
Is This Test for Men or People Undergoing Gender-Affirming Care?
At this time, the test has been validated only for individuals assigned female at birth.
There is currently not enough data to confirm accuracy for men or individuals undergoing gender-affirming hormone therapy. The DNA Company is continuing research to expand the test for additional populations in the future.
Early detection can change everything
before symptoms ever appear.
This simple, non-invasive screening helps identify early signals that may otherwise go unnoticed, giving you the opportunity to take action sooner. Understand how it works, what it detects, and how it supports your long-term health alongside regular screening.
